B

Black Diamond Therapeutics
D

BDTX

2.86500
USD
0.19
(7.10%)
مغلق
حجم التداول
33,806
الربح لكل سهم
-1
العائد الربحي
-
P/E
7
حجم السوق
164,132,269
المقالات
المزيد

العنوان: Black Diamond Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.